SecBot SecBot
DEFA14A ·Filed Apr 28, 2026

EBS

Emergent BioSolutions Inc.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago SEC0001193125-26-186460
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine proxy solicitation communication with no trading implications. Monitor upcoming definitive proxy statement (DEF 14A) for any material proposals or activist-related items, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$8.23
T+0 close · Apr 28, 2026 · via day close
Latest settled
−8.87%
T+60 · $7.50
Vs SPY
−12.86%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 28 $8.23entry
  2. T+1 · 7mo ago −2.92%α −2.91% · $7.99
  3. T+5 · 7mo ago +3.77%α +2.07% · $8.54
  4. T+20 · 6mo ago +10.94%α +5.47% · $9.13
  5. T+60 · 4mo ago −8.87%α −12.86% · $7.50
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Emergent BioSolutions filed a DEFA14A (additional definitive proxy soliciting materials) on April 28, 2026, consisting of a message sent to employees. The filing is a routine communication in connection with the company's proxy solicitation and contains no material financial data, guidance, or substantive corporate action.

Key Facts

  • Filed as additional definitive proxy soliciting materials (DEFA14A) on April 28, 2026
  • Content is an internal message to employees, no financial figures, guidance, or material events disclosed
  • No quantitative data on revenue, earnings, M&A, or other financial metrics in the filing

Financial Impact

No financial impact, filing contains no financial data or material corporate action

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-186460
Document: 0001193125-26-186460-index-headers.html0001193125-26-186460
Document: 0001193125-26-186460-index.html0001193125-26-186460
Document: 0001193125-26-186460.txt0001193125-26-186460

Track record

23 reports on EBS

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +14.89% at T+20 after the Apr 29, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $5.76 Now $5.81 +0.96% settles Nov 23
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.75 Now $5.81 +1.13% settles Nov 23
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.79 Now $5.81 +0.35% settles Nov 23
  4. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $5.85 to $5.89 Now $5.81 −0.68% ▲ +0.68% −2.61% vs SPY
  5. Nov 2, 202614d ago 8-K Bearish 6/10 Entry $6.25 to $6.05 Now $5.81 +7.04% ▲ +3.20% +2.61% vs SPY
  6. Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $6.81 to $6.06 Now $5.81 −14.68% ▼ −11.01% −8.31% vs SPY
  7. Oct 16, 20264w ago 8-K Neutral 3/10 Entry $6.38 to $6.23 Now $5.81 −8.93% ▼ −2.35% −2.44% vs SPY
  8. Oct 7, 20265w ago 144 Neutral 2/10 Entry $6.81 to $7.18 Now $5.81 −14.68% ▲ +5.43% +5.71% vs SPY
  9. Jun 29, 202620w ago 8-K Bullish 5/10 Entry $8.46 to $8.18 Now $5.81 −31.32% ▼ −3.31% −4.70% vs SPY
  10. Jun 4, 202623w ago Press Release Neutral 2/10 Entry $8.44 to $8.39 Now $5.81 −31.16% ▼ −0.59% +1.96% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 28, 2026